top of page
color cloud.png

Rick Doblin

MAPS

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and three children.

color cloud.png

Stay Up to Date

Never miss a deadline. Get the latest to your inbox. 

Thanks for subscribing!

About Psychedelic Medicine – Israel 2026

With the rediscovery of psychedelic drugs as potential treatments for psychiatric disorders, we may be on the verge of the next revolution. The potential impact of psychedelics is not limited to psychiatry. Fields such as neurology, palliative care, addiction and pain medicine are among the potential beneficiaries along with inflammatory and possibly autoimmune disorders. 

Conference Organizer
comtec_med.jpg
bottom of page